Choosing the Right Therapy for Patients with NSCLC

Video Library - Lung Cancer
Edward Garon, MD
Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice.
Related Items
Alectinib New Standard of Care for ALK-Positive Non–Small-Cell Lung Cancer
Phoebe Starr
TOP - November 2017, Vol 10, No 4 published on November 13, 2017 in Lung Cancer
Osimertinib Extends Progression-Free Survival in EGFR T790M–Positive Lung Cancer with CNS Metastases Myeloma
Wayne Kuznar
TOP - November 2017, Vol 10, No 4 published on November 13, 2017 in Lung Cancer
Dacomitinib Represents Potential New Targeted Therapy for EGFR Mutation–Positive Lung Cancer
TOP - November 2017, Vol 10, No 4 published on November 13, 2017 in Lung Cancer
Highlights from Best Practices in Lung Cancer Navigation Summit
TON - Supplements published on May 16, 2017 in Lung Cancer
Managing Immune-Related Toxicities in Patients with Lung Cancer
Meg Barbor, MPH
TOP - May 2017, Vol 10, No 2 published on May 5, 2017 in Lung Cancer
Plinabulin Improves Survival in Non–Small-Cell Lung Cancer
Chase Doyle
TOP - May 2017, Vol 10, No 2 published on May 5, 2017 in Lung Cancer
Projected Long-Term Survival High for Patients with Advanced Non–Small-Cell Lung Cancer Treated with Pembrolizumab
Chase Doyle
TOP - May 2017, Vol 10, No 2 published on May 5, 2017 in Lung Cancer
Smoking Cessation and Lung Cancer
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Screening for Lung Cancer
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Who Should be Screened for Lung Cancer?
Edward Garon, MD
Video Library published on April 27, 2017 in Lung Cancer
Last modified: April 27, 2017